Assuntos
Indústria Farmacêutica/economia , Terapia Genética/economia , Imunoterapia Adotiva/economia , Marketing/economia , Receptores de Antígenos de Linfócitos T/uso terapêutico , Capitalismo , Indústria Farmacêutica/ética , Financiamento Governamental , Organização do Financiamento/economia , Fraude/economia , Setor de Assistência à Saúde/economia , Setor de Assistência à Saúde/ética , Humanos , Neoplasias/terapiaRESUMO
The number of hematopoietic stem cell transplantation is in constant rise. This increase has put in spotlight the lack of physician availability. Some healthcare centers have already organised a nurse's consultation under the supervision of an expert physician. We conducted a survey among nurses and physicians from the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) centers who confirmed the need to create a special transplantation-skilled population of nurses. During this ninth annual workshop of the SFGM-TC, we have defined the required conditions for a transplant nurse consultation until day 100 post-transplant with the responsibility of the transplant expert physician. To help the centers in this dynamic, we provided practical tools to support this consultation. The current heath policy is in favor of an increased autonomy of the expert nurse. The implementation of the status of nurse in advanced practice is the first step in this professional development.
Assuntos
Assistência ao Convalescente , Transplante de Células-Tronco Hematopoéticas/enfermagem , Papel do Profissional de Enfermagem , Especialidades de Enfermagem , Assistência ao Convalescente/métodos , Aloenxertos , Pesquisas sobre Atenção à Saúde , Humanos , Encaminhamento e Consulta , Especialidades de Enfermagem/educaçãoRESUMO
Allogeneic hematopoietic cell transplantation (HCT) is part of the standard of care for many hematological diseases. Over the last decades, significant advances in patient and donor selection, conditioning regimens as well as supportive care of patients undergoing allogeneic HCT leading to improved overall survival have been made. In view of many new treatment options in cellular and molecular targeted therapies, the place of allogeneic transplantation in therapy concepts must be reviewed. Most aspects of HCT are well standardized by national guidelines or laws as well as by certification labels such as FACT-JACIE. However, the requirements for human resources, construction and layout of a unit treating patients during the transplantation procedure and for different complications are not well defined. Here, we describe the process of planning a transplant unit in order to open a discussion that could lead to more precise guidelines in the field of personnel and infrastructural requirements for hospitals caring for people with severe immunosuppression.